Residential College | false |
Status | 已發表Published |
Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy | |
Liu, Mengnan1,2,3; Yuan, Gang1; Luo, Gang2,3; Guo, Xin1; Chen, Mingtai1,4; Yang, Huayi1; He, Fan5; Yang, Tingfu2,3; Zhang, Xinyue6; Wu, Qibiao1,7; Zhou, Hua5; Yang, Sijin1,2 | |
2022-05-02 | |
Source Publication | Evidence-based Complementary and Alternative Medicine |
ISSN | 1741-427X |
Volume | 2022 |
Abstract | Background. Danshen Decoction comprises Salvia miltiorrhiza, Santalum album, and Amomum villosum. It can promote blood circulation and remove blood stasis, and is commonly used in the treatment of gastric and duodenal ulcers, coronary heart disease, angina pectoris, etc. This research is based on network pharmacology and is experimentally verified to explore the potential mechanism of Danshen Decoction in the treatment of ischemic cardiomyopathy (ICM). Methods. The effective components and targets of Danshen Decoction were firstly extracted from Traditional Chinese Medicine Systems Pharmacology (TCMSP) Database and Analysis Platform, the drug-component-target-disease network was then constructed, the protein-protein interaction (PPI) network was constructed, the Gene Ontology (GO) enrichment analysis was carried out, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was analyzed in order to find the potential active components and therapeutic mechanisms. Finally, the in vitro hypoxia/reoxygenation model in H9c2 cells was established to verify the predicted active components and therapeutic mechanisms. Results. The results showed that Danshen Decoction has 67 potential active components and 109 therapeutic targets in treating ICM. These targets were rich in a variety of gene functions and different signaling pathways; the main gene targets include TP53, c-Jun, and Akt1. Go enrichment analysis showed that response to drug, membrane raft, and G protein-coupled amine receiver activity rank first in each process, and the main signaling pathways include PI3K-Akt signaling pathway. Through molecular docking and experimental verification of the major active components and core therapeutic targets, the active components of Danshen Decoction demonstrated an ability to reduce the cell damage caused by hypoxia/reoxygenation in H9c2 cells by regulating the core therapeutic target including Akt1, c-Jun, and TP53. Conclusion. Danshen Decoction has the effect of treating ICM in multiple ways, which is consistent with the results of network pharmacology. This laid a foundation for further study in exploring the active principles and pharmacological mechanism of Danshen Decoction. |
Keyword | Ischemic Cardiomyopathy |
DOI | 10.1155/2022/7578055 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Integrative & Complementary Medicine |
WOS Subject | Integrative & Complementary Medicine |
WOS ID | WOS:000813936500001 |
Scopus ID | 2-s2.0-85132520743 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | University of Macau |
Corresponding Author | Wu, Qibiao; Zhou, Hua; Yang, Sijin |
Affiliation | 1.State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macao 2.National Traditional Chinese Medicine Clinical Research Base, Department of Cardiovascular Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China 3.Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, China 4.Department of Cardiovascular Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China 5.Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, China 6.School of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan, China 7.Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou, China |
First Author Affilication | University of Macau |
Corresponding Author Affilication | University of Macau |
Recommended Citation GB/T 7714 | Liu, Mengnan,Yuan, Gang,Luo, Gang,et al. Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy[J]. Evidence-based Complementary and Alternative Medicine, 2022, 2022. |
APA | Liu, Mengnan., Yuan, Gang., Luo, Gang., Guo, Xin., Chen, Mingtai., Yang, Huayi., He, Fan., Yang, Tingfu., Zhang, Xinyue., Wu, Qibiao., Zhou, Hua., & Yang, Sijin (2022). Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy. Evidence-based Complementary and Alternative Medicine, 2022. |
MLA | Liu, Mengnan,et al."Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy".Evidence-based Complementary and Alternative Medicine 2022(2022). |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment